Showing results (131-140 of 231) with videos related to
Sort By:
Pageof 24
Vaccine|May 16, 2002
Long-term follow-up: no effect of therapeutic vaccination with HIV-1 p17/p24:Ty virus-like particles on HIV-1 disease progressionCatharina E A Lindenburg, Ineke Stolte, Miranda W Langendam, et al.The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|May 21, 2013
Distribution of eating disorders in children and adolescents using the proposed DSM-5 criteria for feeding and eating disordersRollyn M Ornstein, David S Rosen, Kathleen A Mammel, et al.AIDS Research and Therapy|January 29, 2013
NGX-4010, a capsaicin 8% patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: integrated analysis of two phase III, randomized, controlled trialsStephen Brown, David M Simpson, Graeme Moyle, et al.Journal of the International AIDS Society|November 14, 2014
Effects of age on symptom burden, mental health and quality of life amongst people with HIV in the UKJennifer McGowan, Lorraine Sherr, Alison Rodger, et al.AIDS (London, England)|December 5, 2015
The impact of transient combination antiretroviral treatment in early HIV infection on viral suppression and immunologic response in later treatmentNikos Pantazis, Giota Touloumi, Laurence Meyer, et al.Vaccine|October 15, 2013
Safety, immunogenicity and efficacy assessment of HIV immunotherapy in a multi-centre, double-blind, randomised, Placebo-controlled Phase Ib human trialMarta Boffito, Julie Fox, Christine Bowman, et al.Journal of the International AIDS Society|November 15, 2014
Switching from ritonavir to cobicistat in HIV patients with renal impairment who are virologically suppressed on a protease inhibitorMartin Fisher, Cheryl McDonald, Graeme Moyle, et al.Proceedings of the National Academy of Sciences of the United States of America|March 23, 2006
Analysis of protein solvent interactions in glucose dehydrogenase from the extreme halophile Haloferax mediterraneiK Linda Britton, Patrick J Baker, Martin Fisher, et al.HIV Clinical Trials|August 26, 2010
Impact of baseline antiretroviral resistance status on efficacy outcomes among patients receiving maraviroc plus optimized background therapy in the MOTIVATE 1 and 2 trialsMark Nelson, Martin Fisher, Juan Gonzalez-Garcia, et al.AIDS (London, England)|December 20, 2007
Survival following HIV infection of a cohort followed up from seroconversion in the UKFiona M Ewings, Krishnan Bhaskaran, Ken McLean, et al.Pageof 24